Core Laboratories (CLB)
Market Price (9/21/2026): $11.27 | Market Cap: $518.8 MilSector: Energy | Industry: Oil & Gas Equipment & Services
Core Laboratories (CLB)
Market Price (9/21/2026): $11.27Market Cap: $518.8 MilSector: EnergyIndustry: Oil & Gas Equipment & Services
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 5.1% Valuation becoming less expensiveP/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -32% Megatrend and thematic driversMegatrends include Hydrocarbon Efficiency & Optimization. Themes include Advanced Reservoir Characterization, and Production Optimization Technologies. | Weak multi-year price returns2Y Excs Rtn is -69%, 3Y Excs Rtn is -125% | Expensive valuation multiplesP/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 18x Weak revenue growthRev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is 0.6%, Rev Chg QQuarterly Revenue Change % is -4.3% Key risksCLB key risks include [1] intense competition creating significant margin pressures, Show more. |
| Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 5.1% |
| Valuation becoming less expensiveP/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -32% |
| Megatrend and thematic driversMegatrends include Hydrocarbon Efficiency & Optimization. Themes include Advanced Reservoir Characterization, and Production Optimization Technologies. |
| Weak multi-year price returns2Y Excs Rtn is -69%, 3Y Excs Rtn is -125% |
| Expensive valuation multiplesP/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 18x |
| Weak revenue growthRev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is 0.6%, Rev Chg QQuarterly Revenue Change % is -4.3% |
| Key risksCLB key risks include [1] intense competition creating significant margin pressures, Show more. |
Qualitative Assessment
AI Analysis | Feedback
Updated on 9/16/2026
Core Laboratories (CLB) stock has lost about 20% since 5/31/2026 because of the following key factors:
1. Underperforming Fiscal Q2 2026 Revenue.
Core Laboratories reported second quarter 2026 revenue of $124.6 million, which fell short of the consensus estimate of $126.26 million and marked a 4.3% decrease compared to the same period last year. This revenue miss contributed to negative investor sentiment and the stock's decline.
2. Adverse Impact of Geopolitical Conflicts.
Ongoing military conflicts in the Middle East and Russia-Ukraine directly disrupted Core Laboratories' operations, particularly affecting its Reservoir Description segment. These conflicts led to client project delays, disruptions in crude oil trade, and reduced assay laboratory activity, resulting in a 9% year-over-year decline in Reservoir Description revenue to $78.7 million in fiscal Q2 2026. Global cargo movements were also down by 16%, further delaying projects and impacting business.
Show more
Core Laboratories (CLB) stock has lost about 20% since 5/31/2026 because of the following key factors:
1. Underperforming Fiscal Q2 2026 Revenue.
Core Laboratories reported second quarter 2026 revenue of $124.6 million, which fell short of the consensus estimate of $126.26 million and marked a 4.3% decrease compared to the same period last year. This revenue miss contributed to negative investor sentiment and the stock's decline.
2. Adverse Impact of Geopolitical Conflicts.
Ongoing military conflicts in the Middle East and Russia-Ukraine directly disrupted Core Laboratories' operations, particularly affecting its Reservoir Description segment. These conflicts led to client project delays, disruptions in crude oil trade, and reduced assay laboratory activity, resulting in a 9% year-over-year decline in Reservoir Description revenue to $78.7 million in fiscal Q2 2026. Global cargo movements were also down by 16%, further delaying projects and impacting business.
Show more
Updated on 9/16/2026
Core Laboratories (CLB) stock has lost about 20% since 5/31/2026 because of the following key factors:
1. Underperforming Fiscal Q2 2026 Revenue.
Core Laboratories reported second quarter 2026 revenue of $124.6 million, which fell short of the consensus estimate of $126.26 million and marked a 4.3% decrease compared to the same period last year. This revenue miss contributed to negative investor sentiment and the stock's decline.
2. Adverse Impact of Geopolitical Conflicts.
Ongoing military conflicts in the Middle East and Russia-Ukraine directly disrupted Core Laboratories' operations, particularly affecting its Reservoir Description segment. These conflicts led to client project delays, disruptions in crude oil trade, and reduced assay laboratory activity, resulting in a 9% year-over-year decline in Reservoir Description revenue to $78.7 million in fiscal Q2 2026. Global cargo movements were also down by 16%, further delaying projects and impacting business.
3. Downward Revision of Fiscal Year 2026 Earnings Estimates.
Analysts revised their earnings per share forecasts downwards for Core Laboratories for fiscal year 2026. Zacks Research lowered its FY2026 EPS estimate to $0.61 from $0.62, and the consensus outlook for fiscal year 2026 EPS, according to Simply Wall St, decreased from US$0.46 to US$0.41 per share. These reductions signal a more cautious outlook on the company's profitability, influencing the stock's performance.
Show less
Core Laboratories (CLB) stock has lost about 20% since 5/31/2026 because of the following key factors:
1. Underperforming Fiscal Q2 2026 Revenue.
Core Laboratories reported second quarter 2026 revenue of $124.6 million, which fell short of the consensus estimate of $126.26 million and marked a 4.3% decrease compared to the same period last year. This revenue miss contributed to negative investor sentiment and the stock's decline.
2. Adverse Impact of Geopolitical Conflicts.
Ongoing military conflicts in the Middle East and Russia-Ukraine directly disrupted Core Laboratories' operations, particularly affecting its Reservoir Description segment. These conflicts led to client project delays, disruptions in crude oil trade, and reduced assay laboratory activity, resulting in a 9% year-over-year decline in Reservoir Description revenue to $78.7 million in fiscal Q2 2026. Global cargo movements were also down by 16%, further delaying projects and impacting business.
3. Downward Revision of Fiscal Year 2026 Earnings Estimates.
Analysts revised their earnings per share forecasts downwards for Core Laboratories for fiscal year 2026. Zacks Research lowered its FY2026 EPS estimate to $0.61 from $0.62, and the consensus outlook for fiscal year 2026 EPS, according to Simply Wall St, decreased from US$0.46 to US$0.41 per share. These reductions signal a more cautious outlook on the company's profitability, influencing the stock's performance.
Show less
Holding a concentrated position? Know your true downside before the momentum shifts.
Protect Your Wealth →
Stock Movement Drivers
Fundamental Drivers
The -17.6% change in CLB stock from 5/31/2026 to 9/20/2026 was primarily driven by a -15.2% change in the company's Net Income Margin (%).| (LTM values as of) | 5312026 | 9202026 | Change |
|---|---|---|---|
| Stock Price ($) | 13.66 | 11.25 | -17.6% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 525 | 519 | -1.1% |
| Net Income Margin (%) | 5.5% | 4.7% | -15.2% |
| P/E Multiple | 21.7 | 21.3 | -1.9% |
| Shares Outstanding (Mil) | 46 | 46 | 0.1% |
| Cumulative Contribution | -17.6% |
Market Drivers
5/31/2026 to 9/20/2026| Return | Correlation | |
|---|---|---|
| CLB | -17.6% | |
| Market (SPY) | 0.9% | 34.4% |
| Sector (XLE) | 14.2% | 44.6% |
Fundamental Drivers
The -35.9% change in CLB stock from 2/28/2026 to 9/20/2026 was primarily driven by a -24.4% change in the company's Net Income Margin (%).| (LTM values as of) | 2282026 | 9202026 | Change |
|---|---|---|---|
| Stock Price ($) | 17.56 | 11.25 | -35.9% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 518 | 519 | 0.3% |
| Net Income Margin (%) | 6.2% | 4.7% | -24.4% |
| P/E Multiple | 25.3 | 21.3 | -15.9% |
| Shares Outstanding (Mil) | 46 | 46 | 0.5% |
| Cumulative Contribution | -35.9% |
Market Drivers
2/28/2026 to 9/20/2026| Return | Correlation | |
|---|---|---|
| CLB | -35.9% | |
| Market (SPY) | 11.6% | 12.1% |
| Sector (XLE) | 15.8% | 35.2% |
Fundamental Drivers
The -2.0% change in CLB stock from 8/31/2025 to 9/20/2026 was primarily driven by a -18.1% change in the company's Net Income Margin (%).| (LTM values as of) | 8312025 | 9202026 | Change |
|---|---|---|---|
| Stock Price ($) | 11.48 | 11.25 | -2.0% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 517 | 519 | 0.3% |
| Net Income Margin (%) | 5.7% | 4.7% | -18.1% |
| P/E Multiple | 18.1 | 21.3 | 17.7% |
| Shares Outstanding (Mil) | 47 | 46 | 1.3% |
| Cumulative Contribution | -2.0% |
Market Drivers
8/31/2025 to 9/20/2026| Return | Correlation | |
|---|---|---|
| CLB | -2.0% | |
| Market (SPY) | 19.4% | 22.8% |
| Sector (XLE) | 45.7% | 38.0% |
Fundamental Drivers
The -52.8% change in CLB stock from 8/31/2023 to 9/20/2026 was primarily driven by a -39.5% change in the company's Net Income Margin (%).| (LTM values as of) | 8312023 | 9202026 | Change |
|---|---|---|---|
| Stock Price ($) | 23.85 | 11.25 | -52.8% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 510 | 519 | 1.8% |
| Net Income Margin (%) | 7.7% | 4.7% | -39.5% |
| P/E Multiple | 28.2 | 21.3 | -24.6% |
| Shares Outstanding (Mil) | 47 | 46 | 1.4% |
| Cumulative Contribution | -52.8% |
Market Drivers
8/31/2023 to 9/20/2026| Return | Correlation | |
|---|---|---|
| CLB | -52.8% | |
| Market (SPY) | 75.6% | 34.9% |
| Sector (XLE) | 58.1% | 56.0% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| CLB Return | -16% | -9% | -13% | -2% | -7% | -29% | -56% |
| Peers Return | 1512% | 64% | 20% | -16% | 9% | 25% | 3573% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 12% | 103% |
Monthly Win Rates [3] | |||||||
| CLB Win Rate | 33% | 50% | 33% | 50% | 50% | 22% | |
| Peers Win Rate | 45% | 65% | 52% | 42% | 67% | 58% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 44% | |
Max Drawdowns [4] | |||||||
| CLB Max Drawdown | -54% | -62% | -39% | -33% | -52% | -50% | |
| Peers Max Drawdown | -28% | -44% | -30% | -33% | -34% | -24% | |
| S&P 500 Max Drawdown | -5% | -25% | -10% | -8% | -19% | -9% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: SLB, HAL, BKR, WFRD, NOV. See CLB Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 9/18/2026 (YTD)
How Low Can It Go
| Event | CLB | S&P 500 |
|---|---|---|
| 2025 US Tariff Shock | ||
| % Loss | -37.2% | -18.8% |
| % Gain to Breakeven | 59.2% | 23.1% |
| Time to Breakeven | 199 days | 79 days |
| Summer-Fall 2023 Five Percent Yield Shock | ||
| % Loss | -31.2% | -9.5% |
| % Gain to Breakeven | 45.3% | 10.5% |
| Time to Breakeven | 231 days | 24 days |
| 2023 SVB Regional Banking Crisis | ||
| % Loss | -22.6% | -6.7% |
| % Gain to Breakeven | 29.1% | 7.1% |
| Time to Breakeven | 83 days | 31 days |
| 2022 Inflation Shock & Fed Tightening | ||
| % Loss | -45.4% | -24.5% |
| % Gain to Breakeven | 83.0% | 32.4% |
| Time to Breakeven | 119 days | 427 days |
| 2020 COVID-19 Crash | ||
| % Loss | -75.6% | -33.7% |
| % Gain to Breakeven | 310.0% | 50.9% |
| Time to Breakeven | 301 days | 140 days |
| 2016-2017 Trump Reflation Bond Selloff | ||
| % Loss | -10.1% | -3.7% |
| % Gain to Breakeven | 11.3% | 3.9% |
| Time to Breakeven | 7 days | 6 days |
In The Past
Core Laboratories's stock fell -37.2% during the 2025 US Tariff Shock. Such a loss loss requires a 59.2% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
| Event | CLB | S&P 500 |
|---|---|---|
| 2025 US Tariff Shock | ||
| % Loss | -37.2% | -18.8% |
| % Gain to Breakeven | 59.2% | 23.1% |
| Time to Breakeven | 199 days | 79 days |
| Summer-Fall 2023 Five Percent Yield Shock | ||
| % Loss | -31.2% | -9.5% |
| % Gain to Breakeven | 45.3% | 10.5% |
| Time to Breakeven | 231 days | 24 days |
| 2023 SVB Regional Banking Crisis | ||
| % Loss | -22.6% | -6.7% |
| % Gain to Breakeven | 29.1% | 7.1% |
| Time to Breakeven | 83 days | 31 days |
| 2022 Inflation Shock & Fed Tightening | ||
| % Loss | -45.4% | -24.5% |
| % Gain to Breakeven | 83.0% | 32.4% |
| Time to Breakeven | 119 days | 427 days |
| 2020 COVID-19 Crash | ||
| % Loss | -75.6% | -33.7% |
| % Gain to Breakeven | 310.0% | 50.9% |
| Time to Breakeven | 301 days | 140 days |
| 2011 US Debt Ceiling Crisis & European Contagion | ||
| % Loss | -21.6% | -17.9% |
| % Gain to Breakeven | 27.6% | 21.8% |
| Time to Breakeven | 25 days | 123 days |
| 2008-2009 Global Financial Crisis | ||
| % Loss | -58.1% | -53.4% |
| % Gain to Breakeven | 138.9% | 114.4% |
| Time to Breakeven | 389 days | 1085 days |
In The Past
Core Laboratories's stock fell -37.2% during the 2025 US Tariff Shock. Such a loss loss requires a 59.2% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About Core Laboratories (CLB)
Core Laboratories (CLB) is a global oilfield services company that provides specialized products and services to the international oil and gas industry. The company helps its clients optimize oil and gas production through two primary business segments: understanding the reservoir and enhancing production from wells.
In its Reservoir Description segment, Core Laboratories offers advanced laboratory and field services to analyze petroleum reservoir rock, fluid, and gas samples. This detailed characterization helps clients better understand their reserves, predict production behavior, and ultimately improve the recovery of oil and gas. The company also provides analytical services for crude oil properties and conducts proprietary and joint industry studies to further industry knowledge.
The Production Enhancement segment focuses on improving the effectiveness of oil and gas wells. This includes providing services and products related to well completions, perforations, stimulations, and ongoing production. Core Laboratories offers integrated diagnostic services to evaluate and monitor how effectively wells are completed and to develop solutions that improve the success of enhanced oil recovery projects. Its primary customers are oil and gas companies operating globally in approximately 50 countries, including the United States and Canada.
AI Analysis | Feedback
Here are 1-3 brief analogies for Core Laboratories (CLB):
They're like **LabCorp or Quest Diagnostics, but for oil and gas reservoirs,** performing detailed analyses on rock, fluid, and gas samples to understand and optimize oil recovery.
Think of them as the **IQVIA of the oil and gas industry,** providing highly specialized data, analytics, and services to help producers understand and optimize the performance of their reservoirs and wells.
AI Analysis | Feedback
- Reservoir Characterization Services: Analyzing petroleum reservoir rock, fluid, and gas samples to enhance production and improve oil and gas recovery.
- Oil and Gas Product Analysis: Providing laboratory-based analytical and field services to characterize the properties of crude oil and oil-delivered products.
- Proprietary and Joint Industry Studies: Conducting specialized research and collaborative studies for the oil and gas industry.
- Well Completion, Perforation, and Stimulation Services: Offering services and products related to reservoir well completions, perforations, and stimulations.
- Production Enhancement Services: Providing services and products to optimize the ongoing production of oil and gas from wells.
- Integrated Diagnostic Services: Evaluating and monitoring the effectiveness of well completions and developing solutions for improving enhanced oil recovery projects.
AI Analysis | Feedback
Core Laboratories (CLB) sells its services and products primarily to other companies within the global oil and gas industry.
Based on the company's public filings, Core Laboratories does not depend on a single customer or a small group of customers, the loss of which would have a material adverse effect on the company. Therefore, no specific "major customers" accounting for a significant portion of their revenue are individually disclosed by name.
Instead, Core Laboratories serves a diverse global client base which can be categorized into three main types of oil and gas companies:
-
International Oil Companies (IOCs): These are large, publicly traded multinational corporations involved in various aspects of the oil and gas industry globally.
- Examples include: ExxonMobil (XOM), Chevron (CVX), Shell plc (SHEL), BP p.l.c. (BP), TotalEnergies SE (TTE)
-
National Oil Companies (NOCs): These are state-owned or state-controlled entities that manage oil and gas resources within their respective countries. While some may have publicly traded shares, they are primarily government-owned.
- Examples include: Saudi Aramco, Abu Dhabi National Oil Company (ADNOC), Petrobras (PBR), Petróleos Mexicanos (PEMEX), Equinor ASA (EQNR)
-
Independent Oil and Gas Companies: These are typically smaller to mid-sized, often publicly traded companies that focus primarily on the exploration and production of oil and natural gas, often within specific geographic regions.
- Examples include: EOG Resources (EOG), Occidental Petroleum (OXY), Marathon Oil (MRO), Hess Corporation (HES)
AI Analysis | Feedback
null
AI Analysis | Feedback
Lawrence V. Bruno, Chairman of the Board, CEO, President & COO
Mr. Bruno became President of Core Laboratories on February 1, 2018, and assumed the position of Chief Operating Officer on January 1, 2019. On May 20, 2020, he succeeded Mr. David Demshur as Chairman and Chief Executive Officer. He has been in the industry for over 30 years, with 20 of those years at Core Laboratories (as of February 2018), initially serving as Vice President, Reservoir Description. He is an innovative technologist with a Master's degree in geology.
Christopher S. Hill, Senior Vice President & CFO
Mr. Hill assumed the role of Chief Financial Officer on May 24, 2018, after holding the position of Vice President, Chief Accounting Officer from May 2015 to May 2018. He joined Core Laboratories in October 2006 and has held various roles, including an overseas assignment in the Netherlands overseeing the company's global shared service centers and leading Investor Relations. Prior to joining Core Laboratories, Mr. Hill served as Controller for the Energy & Chemicals division at Halliburton from March 2005 to October 2006, and as Director of Training and Accounting Research at Halliburton from August 2000 to March 2005. He began his professional career as a Manager at Ernst & Young from January 1993 to August 2000.
Gwendolyn Y. Gresham, Senior Vice President, Corporate Development and Investor Relations
Since 2016, Ms. Gresham has served as Senior Vice President, Corporate Development and Investor Relations, where she leads the Company's Sustainability, Investor Relations, Risk Management, and Human Resources functions. She joined Core Laboratories in October 2006 and previously served as Corporate Vice President based in Amsterdam from 2013 to 2016 and as Director of U.S. Human Resources from 2006 to 2013.
Mark Damian Tattoli, Senior Vice President, Secretary and General Counsel
Mr. Tattoli became Senior Vice President, Secretary and General Counsel on July 1, 2021, having previously served as Assistant General Counsel since November 2012. He is responsible for overseeing all legal and compliance matters for the Company. Mr. Tattoli brings 20 years of experience in the petroleum industry, working as both in-house and outside counsel across upstream, midstream, and downstream sectors.
Sow Hang Teo, Vice President, Treasurer & Chief Accounting Officer
Mr. Teo holds the position of Vice President, Treasurer and Chief Accounting Officer at Core Laboratories.
AI Analysis | Feedback
The key risks to Core Laboratories (CLB) are primarily driven by external market forces and the inherent volatility of the oil and gas industry.
Key Risks
- Geopolitical Instability and Sanctions: Core Laboratories' international operations are significantly vulnerable to geopolitical conflicts, such as those in Eastern Europe and the Middle East, and expanded sanctions. These events have demonstrably disrupted product deliveries, crude assay services, and overall operational efficiency, leading to deferred revenues and uncertainty in international revenue streams. The company has experienced temporary operational inefficiencies and declining revenues and operating income directly linked to these geopolitical factors.
- Volatile Crude Oil Prices and Market Competition: The company's performance is closely tied to the highly volatile crude oil prices, influenced by global economic and geopolitical uncertainties. Additionally, Core Laboratories operates in a highly competitive and fragmented oilfield services market, facing pressure from larger, integrated service providers and specialized niche players. This competitive landscape, coupled with weaknesses in key markets like the U.S. onshore due to low natural gas prices and industry consolidation, contributes to declining revenues and margin compression.
- Dependency on Client Geological Success Rates: A significant portion of Core Laboratories' revenue, particularly from its high-margin reservoir description services on international projects, is explicitly dependent on its clients' geological success rates. If exploration and appraisal wells drilled by its clients are unsuccessful, the extensive reservoir description work that would typically follow may be reduced or canceled, directly impacting Core Laboratories' anticipated growth and revenue.
AI Analysis | Feedback
The clear emerging threat for Core Laboratories (CLB) is the accelerating global transition to renewable energy sources and decarbonization efforts. As an oil and gas services company, CLB's core business of reservoir description and production enhancement is fundamentally tied to the continued exploration, production, and demand for fossil fuels. A sustained and accelerating shift away from oil and gas, driven by climate policies and technological advancements in renewables, poses a long-term existential threat to the demand for CLB's services, akin to how streaming services eroded the market for physical video rentals.
AI Analysis | Feedback
Core Laboratories' Addressable Market Sizes for Key Services and Products
Core Laboratories N.V. (NYSE: CLB) operates within the broader oil and gas industry, providing specialized services and products across two main segments: Reservoir Description and Production Enhancement. The addressable markets for its offerings are substantial, driven by ongoing global energy demand and the need for optimized hydrocarbon recovery.Reservoir Description Segment
For Core Laboratories' Reservoir Description segment, which includes the characterization of petroleum reservoir rock, fluid, and gas samples, and related analytical and field services, the **global reservoir analysis market** is a direct addressable market. This market was valued at approximately USD 9.73 billion in 2025 and is projected to reach USD 15.36 billion by 2034, growing at a compound annual growth rate (CAGR) of 3.45% during the forecast period. North America is a significant region within this market, holding a 38.47% share in 2025. Another report indicates the global reservoir analysis market was valued at USD 8.98 billion in 2022 and is expected to grow to USD 13.36 billion by 2030, with a CAGR of 5.1% from 2023-2030. The global conventional reservoir analysis market alone is projected to expand from USD 6.96 billion in 2025 to USD 8.69 billion by 2031, with a CAGR of 3.77%.Production Enhancement Segment
For Core Laboratories' Production Enhancement segment, which focuses on reservoir well completions, perforations, stimulations, and enhanced oil recovery (EOR) projects, the following markets are relevant: * **Enhanced Oil Recovery (EOR) Market:** The **global Enhanced Oil Recovery (EOR) market** is a key addressable market. It was valued at approximately USD 60.30 billion in 2025 and is predicted to increase to about USD 118.64 billion by 2035, expanding at a CAGR of 7% from 2026 to 2035. North America is projected to dominate the EOR market, accounting for a 39% market share in 2025. Other estimates for the global EOR market size include USD 52.3 billion in 2024, projected to reach USD 79.7 billion by 2034 at a CAGR of 4.7% from 2025 to 2034 and USD 58.0 billion in 2025, projected to reach USD 90.0 billion by 2035 at a CAGR of 4.5%. * **Well Completion Equipment and Services Market:** The **global well completion equipment and services market** is another significant addressable market for the Production Enhancement segment. This market was valued at approximately USD 11.75 billion in 2024, USD 25.61 billion in 2025, and USD 12.22 billion in 2025. Projections indicate growth to USD 18.02 billion by 2035 at a CAGR of 8.8% from 2026 to 2035, and to USD 40.19 billion by 2034 with a CAGR of 5.11% from 2026. North America held a significant share of this market, with approximately 40.7% of global revenue in 2024.Broader Oilfield Services Market
Core Laboratories' services also fall under the broader **global oilfield services market**. This market was estimated at USD 133.1 billion in 2023 and is projected to reach USD 166.4 billion by 2030, growing at a CAGR of 3.4% from 2024 to 2030. Other estimates include USD 133.33 billion in 2025, projected to reach USD 201.19 billion by 2035 at a CAGR of 4.2%, and USD 126.32 billion in 2025, expected to reach USD 167.69 billion by 2030 at a CAGR of 5.83%. The analytical and consulting segment within oilfield services is expected to witness the fastest CAGR growth of 4.4% over the forecast period. North America dominated the oilfield services market with a revenue share of 31.95% in 2023.AI Analysis | Feedback
Core Laboratories (CLB) is anticipated to drive future revenue growth over the next 2-3 years through several key areas:
- Strong International and Offshore Activity: Core Laboratories expects continued robust demand for its proprietary technologies and services in international and offshore markets. The company's Reservoir Description segment, which accounts for approximately 80% of its revenues from non-U.S. projects, is particularly poised for growth due to ongoing international and offshore activity levels. This includes sustained demand for rock and fluid analysis across its global laboratory network.
- Increased Adoption of Proprietary Production Enhancement Technologies and Diagnostic Services: The Production Enhancement segment is projected to grow through the expanding adoption of Core Laboratories' proprietary technologies, including advanced energetic systems, and its diagnostic services. These offerings are expected to partially offset any softer U.S. onshore activity, with increased demand for completion diagnostic services in international regions contributing to revenue.
- Sustained Global Investment in Oil and Gas Development: Forecasts from the IEA, EIA, and OPEC indicate continued growth in global crude oil demand through 2025 and 2026. This demand, coupled with accelerating natural decline rates in existing producing fields, necessitates sustained investment in new oil and gas development, particularly outside the continental U.S. This ongoing investment in field development will drive demand for Core Laboratories' reservoir description and production enhancement services.
- Expansion into Energy Transition Projects: Core Laboratories is actively engaging in and leveraging its analytical services for energy transition projects, such as Carbon Capture and Sequestration (CCS). The company notes growing client activity and momentum in CCS projects, reinforcing its role in these evolving energy initiatives.
AI Analysis | Feedback
Share Repurchases
- In 2025, Core Laboratories repurchased approximately 1.2 million shares of common stock for an aggregate purchase price of $15.5 million, including 363,207 shares for $5.7 million in the fourth quarter.
- During the fourth quarter of 2024, the company repurchased 264,982 shares of common stock for $4.9 million, contributing to a total of $5.3 million in share buybacks for the full fiscal year 2024.
- In January 2022, Core Laboratories repurchased 55,948 common shares at an average price of $25.71 per share as part of its existing share repurchase program.
Share Issuance
- On June 9, 2022, Core Laboratories announced a $60 million At-The-Market (ATM) equity offering program, although no shares had been sold under this program as of September 30, 2022.
Outbound Investments
- On October 1, 2025, Core Laboratories acquired Brazil-based Solintec Consultoria E Servicos De Geologia Ltda. for an initial cash payment of approximately $2.3 million.
Capital Expenditures
- For 2026, Core Laboratories expects capital expenditures to be in the range of $15 million to $18 million, primarily focused on growth opportunities.
- In 2025, capital expenditures totaled $3.4 million for the full year, with $2.9 million in the fourth quarter.
- Capital expenditures for fiscal year 2024 were $13.0 million, representing a 23.1% increase from the prior year.
Peer Outperformance in Oil & Gas Equipment & Services
CLB has trailed 97% of its 33 Oil & Gas Equipment & Services peers over 5Y. Among the peers that beat it are WFRD, WTTR and HAL. Oil & Gas Equipment & Services ranks 4th of 7 industries in Energy by median 5Y return. The sector’s gains have largely come from elsewhere.
Share of Oil & Gas Equipment & Services constituents that CLB has outperformed, by holding period. Peers without a full price history over a given window are excluded from that window.
1Y
5%
of 39 industry peers · -5.7% return
3Y
5%
of 37 industry peers · -52.4% return
5Y
3%
of 33 industry peers · -58.0% return
Oil & Gas Equipment & Services peers with revenue growth within 4pp of CLB's that beat it on at least 2 of 3 windows, and by at least 20pp over 5Y. Growth is matched by construction, so the gap is largely a re-rating gap. The multiple column is the context for it.
| Ticker | Name | Rev Growth 3Y Avg | P/E | 1Y | 3Y | 5Y | 5Y Gap |
|---|---|---|---|---|---|---|---|
| CLB | Core Laboratories | 0.6% | 21.3x | -5.7% | -52.4% | -58.0% | — |
| WFRD | Weatherford International | 0.3% | 16.1x | 30.2% | -6.6% | 418.1% | +476pp |
| WTTR | Select Water Solutions | -3.2% | 80.0x | 112.3% | 178.1% | 362.2% | +420pp |
| HAL | Halliburton | 0.0% | 17.6x | 52.5% | -11.6% | 90.4% | +148pp |
| NOV | NOV | 2.7% | 75.8x | 62.6% | 7.2% | 78.4% | +136pp |
Price returns, excluding dividends. P/E shown for context only and not used for matching.
Median price return by industry across the Energy sector, ranked by 5Y. Oil & Gas Equipment & Services is CLB's own industry. Use this to see which corners of the sector have carried the returns.
| Industry | Names | 1Y med | 3Y med | 5Y med | Top 3 by 5Y |
|---|---|---|---|---|---|
| Oil & Gas Refining & Marketing | 11 | 127.9% | 120.7% | 484.3% | PBF 748% · MPC 721% · VLO 662% |
| Integrated Oil & Gas | 7 | 41.9% | 57.3% | 263.3% | IMO 435% · SU 355% · CVE 340% |
| Oil & Gas Storage & Transportation | 18 | 33.9% | 116.5% | 212.0% | INSW 1041% · LPG 981% · TRGP 626% |
| Oil & Gas Equipment & Services ← | 34 | 49.6% | 21.9% | 117.8% | SEI 1073% · FTI 1002% · TDW 700% |
| Coal & Consumable Fuels | 14 | -10.0% | 33.0% | 94.7% | EU 799% · CCJ 340% · CNR 327% |
| Oil & Gas Drilling | 7 | 66.4% | 3.8% | 94.3% | PDS 169% · VAL 166% · NE 99% |
| Oil & Gas Exploration & Production | 51 | 28.9% | 15.1% | 93.5% | KGEI 10187% · OBE 7421% · EP 2332% |
Median of constituents with a full price history over each window. Top names are unfiltered by size in this render.
Latest Trefis Analyses
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 42.38 |
| Mkt Cap | 17.7 |
| Rev LTM | 15,506 |
| Op Inc LTM | 1,778 |
| FCF LTM | 1,144 |
| FCF 3Y Avg | 1,364 |
| CFO LTM | 1,833 |
| CFO 3Y Avg | 2,189 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 0.4% |
| Rev Chg 3Y Avg | 1.6% |
| Rev Chg Q | -2.4% |
| QoQ Delta Rev Chg LTM | -0.6% |
| Op Inc Chg LTM | -15.8% |
| Op Inc Chg 3Y Avg | 0.9% |
| Op Mgn LTM | 12.9% |
| Op Mgn 3Y Avg | 13.9% |
| QoQ Delta Op Mgn LTM | -0.5% |
| CFO/Rev LTM | 13.6% |
| CFO/Rev 3Y Avg | 14.0% |
| FCF/Rev LTM | 9.4% |
| FCF/Rev 3Y Avg | 8.8% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 17.7 |
| P/S | 1.2 |
| P/Op Inc | 13.4 |
| P/EBIT | 13.3 |
| P/E | 19.8 |
| P/CFO | 10.9 |
| Total Yield | 6.7% |
| Dividend Yield | 1.8% |
| FCF Yield 3Y Avg | 8.2% |
| D/E | 0.3 |
| Net D/E | 0.1 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | -6.4% |
| 3M Rtn | -2.4% |
| 6M Rtn | -4.3% |
| 12M Rtn | 41.2% |
| 3Y Rtn | -6.4% |
| 1M Excs Rtn | -6.8% |
| 3M Excs Rtn | -4.4% |
| 6M Excs Rtn | -21.2% |
| 12M Excs Rtn | 24.4% |
| 3Y Excs Rtn | -81.6% |
Comparison Analyses
Segment Financials
Revenue by Segment| $ Mil | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Reservoir Description | 348 | 346 | 334 | 308 | 314 |
| Production Enhancement | 179 | 178 | 177 | 182 | 157 |
| Corporate & Other | -0 | -0 | -0 | -1 | -1 |
| Total | 527 | 524 | 510 | 490 | 470 |
| $ Mil | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Reservoir Description | 44 | 51 | 41 | 23 | 29 |
| Production Enhancement | 12 | 7 | 13 | 16 | 15 |
| Corporate & Other | 0 | 0 | 1 | 2 | 1 |
| Total | 56 | 59 | 55 | 42 | 45 |
| $ Mil | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Reservoir Description | 332 | 317 | 309 | 307 | 305 |
| Production Enhancement | 141 | 149 | 161 | 160 | 142 |
| Corporate & Other | 111 | 118 | 116 | 112 | 133 |
| Total | 584 | 585 | 586 | 578 | 581 |
Price Behavior
Price Behavior
| Market Price | $11.25 | |
| Market Cap ($ Bil) | 0.5 | |
| First Trading Date | 09/21/1995 | |
| Distance from 52W High | -42.7% | |
| 50 Days | 200 Days | |
| DMA Price | $11.81 | $14.88 |
| DMA Trend | down | indeterminate |
| Distance from DMA | -4.8% | -24.4% |
| 3M | 1YR | |
| Volatility | 45.6% | 55.7% |
| Downside Capture | 106.80 | 125.69 |
| Upside Capture | 75.63 | 97.26 |
| Correlation (SPY) | 34.5% | 22.3% |
CLB Betas & Captures as of 8/31/2026
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | 1.55 | 1.58 | 1.26 | 0.41 | 0.98 | 1.16 |
| Up Beta | 1.90 | 2.96 | 0.75 | -0.48 | 0.06 | 1.16 |
| Down Beta | 7.01 | 4.63 | 2.38 | 0.74 | 1.59 | 1.42 |
| Up Capture | 183% | 48% | 75% | 15% | 99% | 49% |
| Bmk +ve Days | 10 | 21 | 32 | 68 | 138 | 427 |
| Stock +ve Days | 15 | 24 | 33 | 61 | 128 | 359 |
| Down Capture | -120% | -9% | 126% | 115% | 109% | 106% |
| Bmk -ve Days | 11 | 21 | 32 | 59 | 113 | 324 |
| Stock -ve Days | 6 | 18 | 31 | 65 | 121 | 386 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with CLB | |
|---|---|---|---|---|
| CLB | -9.6% | 55.7% | 0.01 | - |
| Sector ETF (XLE) | 46.5% | 21.8% | 1.66 | 39.2% |
| Equity (SPY) | 16.9% | 12.9% | 0.94 | 22.4% |
| Gold (GLD) | 19.1% | 29.3% | 0.60 | 8.7% |
| Commodities (DBC) | 46.3% | 20.6% | 1.73 | 25.1% |
| Real Estate (VNQ) | 4.9% | 13.6% | 0.10 | 7.8% |
| Bitcoin (BTCUSD) | -30.6% | 44.3% | -0.70 | 14.1% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with CLB | |
|---|---|---|---|---|
| CLB | -16.4% | 53.7% | -0.14 | - |
| Sector ETF (XLE) | 26.3% | 25.7% | 0.89 | 61.7% |
| Equity (SPY) | 12.9% | 17.2% | 0.57 | 34.6% |
| Gold (GLD) | 19.1% | 18.8% | 0.83 | 13.8% |
| Commodities (DBC) | 11.2% | 19.5% | 0.45 | 41.6% |
| Real Estate (VNQ) | 1.1% | 18.8% | -0.05 | 25.3% |
| Bitcoin (BTCUSD) | 12.5% | 52.5% | 0.42 | 18.9% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with CLB | |
|---|---|---|---|---|
| CLB | -19.8% | 55.2% | -0.17 | - |
| Sector ETF (XLE) | 10.3% | 29.6% | 0.38 | 67.7% |
| Equity (SPY) | 15.1% | 18.0% | 0.72 | 40.4% |
| Gold (GLD) | 12.1% | 16.4% | 0.61 | 8.9% |
| Commodities (DBC) | 8.3% | 18.1% | 0.37 | 45.1% |
| Real Estate (VNQ) | 4.4% | 20.7% | 0.18 | 29.7% |
| Bitcoin (BTCUSD) | 62.6% | 66.2% | 1.02 | 13.6% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Returns Analyses
Earnings Returns History
Updated 8/31/2026| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 7/29/2026 | 4.9% | 10.9% | 24.6% |
| 4/29/2026 | -15.3% | -21.0% | -20.9% |
| 2/4/2026 | -4.2% | -3.4% | -18.8% |
| 10/22/2025 | 28.8% | 26.2% | 8.8% |
| 7/23/2025 | 5.9% | -11.7% | -17.0% |
| 4/23/2025 | -3.8% | -5.8% | -9.5% |
| 1/29/2025 | -4.3% | -3.8% | -21.0% |
| 10/23/2024 | 10.9% | 12.9% | 23.7% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 7 | 5 | 4 |
| # Negative | 6 | 8 | 9 |
| Median Positive | 5.9% | 11.2% | 16.7% |
| Median Negative | -4.2% | -6.6% | -17.0% |
| Max Positive | 28.8% | 26.2% | 24.6% |
| Max Negative | -15.3% | -21.0% | -21.0% |
| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 7/29/2026 | 4.9% | 10.9% | 24.6% |
| 4/29/2026 | -15.3% | -21.0% | -20.9% |
| 2/4/2026 | -4.2% | -3.4% | -18.8% |
| 10/22/2025 | 28.8% | 26.2% | 8.8% |
| 7/23/2025 | 5.9% | -11.7% | -17.0% |
| 4/23/2025 | -3.8% | -5.8% | -9.5% |
| 1/29/2025 | -4.3% | -3.8% | -21.0% |
| 10/23/2024 | 10.9% | 12.9% | 23.7% |
| 7/24/2024 | 10.6% | 11.2% | -17.7% |
| 4/24/2024 | 3.3% | -5.0% | 9.7% |
| 1/31/2024 | -4.7% | -7.4% | -1.9% |
| 11/1/2023 | 1.1% | -9.9% | -14.0% |
| 7/26/2023 | -0.8% | 4.8% | -4.7% |
| SUMMARY STATS | |||
| # Positive | 7 | 5 | 4 |
| # Negative | 6 | 8 | 9 |
| Median Positive | 5.9% | 11.2% | 16.7% |
| Median Negative | -4.2% | -6.6% | -17.0% |
| Max Positive | 28.8% | 26.2% | 24.6% |
| Max Negative | -15.3% | -21.0% | -21.0% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 06/30/2026 | 07/30/2026 | 10-Q |
| 03/31/2026 | 05/01/2026 | 10-Q |
| 12/31/2025 | 03/23/2026 | 10-K |
| 09/30/2025 | 10/23/2025 | 10-Q |
| 06/30/2025 | 07/25/2025 | 10-Q |
| 03/31/2025 | 04/28/2025 | 10-Q |
| 12/31/2024 | 02/13/2025 | 10-K |
| 09/30/2024 | 10/24/2024 | 10-Q |
| 06/30/2024 | 07/25/2024 | 10-Q |
| 03/31/2024 | 04/25/2024 | 10-Q |
| 12/31/2023 | 02/15/2024 | 10-K |
| 09/30/2023 | 11/02/2023 | 10-Q |
| 06/30/2023 | 07/27/2023 | 10-Q |
| 03/31/2023 | 04/27/2023 | 10-Q |
| 12/31/2022 | 02/10/2023 | 10-K |
| 09/30/2022 | 10/28/2022 | 10-Q |
| Report Date | Filing Date | Filing |
|---|---|---|
| 06/30/2026 | 07/30/2026 | 10-Q |
| 03/31/2026 | 05/01/2026 | 10-Q |
| 12/31/2025 | 03/23/2026 | 10-K |
| 09/30/2025 | 10/23/2025 | 10-Q |
| 06/30/2025 | 07/25/2025 | 10-Q |
| 03/31/2025 | 04/28/2025 | 10-Q |
| 12/31/2024 | 02/13/2025 | 10-K |
| 09/30/2024 | 10/24/2024 | 10-Q |
| 06/30/2024 | 07/25/2024 | 10-Q |
| 03/31/2024 | 04/25/2024 | 10-Q |
| 12/31/2023 | 02/15/2024 | 10-K |
| 09/30/2023 | 11/02/2023 | 10-Q |
| 06/30/2023 | 07/27/2023 | 10-Q |
| 03/31/2023 | 04/27/2023 | 10-Q |
| 12/31/2022 | 02/10/2023 | 10-K |
| 09/30/2022 | 10/28/2022 | 10-Q |
| 06/30/2022 | 07/28/2022 | 10-Q |
| 03/31/2022 | 04/28/2022 | 10-Q |
| 12/31/2021 | 02/10/2022 | 10-K |
| 09/30/2021 | 10/29/2021 | 10-Q |
| 06/30/2021 | 07/30/2021 | 10-Q |
| 03/31/2021 | 04/23/2021 | 10-Q |
| 12/31/2020 | 02/08/2021 | 10-K |
| 09/30/2020 | 10/22/2020 | 10-Q |
| 06/30/2020 | 07/24/2020 | 10-Q |
| 03/31/2020 | 04/24/2020 | 10-Q |
| 12/31/2019 | 02/10/2020 | 10-K |
| 09/30/2019 | 10/25/2019 | 10-Q |
Recent Forward Guidance
Updated 7/30/2026Latest: Q2 2026 Earnings Reported 7/29/2026
| Forward Guidance | Guidance Change | |||||||
|---|---|---|---|---|---|---|---|---|
| Metric | Source | Low | Mid | High | % Chg | % Delta | Change | Prior |
| Q3 2026 Revenue | Reported | 128.50 Mil | 132.00 Mil | 135.50 Mil | 3.9% | Higher New | Guidance: 127.00 Mil for Q2 2026 | |
| Q3 2026 Reservoir Description Revenue | Reported | 81.00 Mil | 82.50 Mil | 84.00 Mil | 3.1% | Higher New | Guidance: 80.00 Mil for Q2 2026 | |
| Q3 2026 Production Enhancement Revenue | Reported | 47.50 Mil | 49.50 Mil | 51.50 Mil | 5.3% | Higher New | Guidance: 47.00 Mil for Q2 2026 | |
| Q3 2026 Operating Income | Reported | 10.50 Mil | 12.75 Mil | 15.00 Mil | 53.6% | Higher New | Guidance: 8.30 Mil for Q2 2026 | |
| Q3 2026 Reservoir Description Operating Income | Reported | 5.50 Mil | 6.70 Mil | 7.90 Mil | 51.0% | Higher New | Guidance: 4.44 Mil for Q2 2026 | |
| Q3 2026 Production Enhancement Operating Income | Reported | 4.80 Mil | 5.85 Mil | 6.90 Mil | 56.0% | Higher New | Guidance: 3.75 Mil for Q2 2026 | |
| Q3 2026 EPS | Reported | 0.12 | 0.16 | 0.2 | 77.8% | Higher New | Guidance: 0.09 for Q2 2026 | |
Prior: Q1 2026 Earnings Reported 4/29/2026
| Forward Guidance | Guidance Change | |||||||
|---|---|---|---|---|---|---|---|---|
| Metric | Source | Low | Mid | High | % Chg | % Delta | Change | Prior |
| Q2 2026 Reservoir Description Revenue | Reported | 77.50 Mil | 80.00 Mil | 82.50 Mil | -4.8% | Lower New | Guidance: 84.00 Mil for Q1 2026 | |
| Q2 2026 Production Enhancement Revenue | Reported | 45.50 Mil | 47.00 Mil | 48.50 Mil | 9.3% | Higher New | Guidance: 43.00 Mil for Q1 2026 | |
| Q2 2026 Revenue | Reported | 123.00 Mil | 127.00 Mil | 131.00 Mil | 0 | Same New | Guidance: 127.00 Mil for Q1 2026 | |
| Q2 2026 Reservoir Description Operating Income | Reported | 3.50 Mil | 4.44 Mil | 5.38 Mil | -41.0% | Lower New | Guidance: 7.53 Mil for Q1 2026 | |
| Q2 2026 Production Enhancement Operating Income | Reported | 2.80 Mil | 3.75 Mil | 4.70 Mil | 13.6% | Higher New | Guidance: 3.30 Mil for Q1 2026 | |
| Q2 2026 Operating Income | Reported | 6.40 Mil | 8.30 Mil | 10.20 Mil | -24.2% | Lower New | Guidance: 10.95 Mil for Q1 2026 | |
| Q2 2026 Operating Margin | Reported | 7.0% | ||||||
| Q2 2026 EPS | Reported | 0.06 | 0.09 | 0.12 | -30.8% | -4.0% | Lower New | Guidance: 0.13 for Q1 2026 |
Q4 2025 Earnings Reported 2/4/2026
| Forward Guidance | Guidance Change | |||||||
|---|---|---|---|---|---|---|---|---|
| Metric | Source | Low | Mid | High | % Chg | % Delta | Change | Prior |
| Q1 2026 Reservoir Description Revenue | Reported | 82.00 Mil | 84.00 Mil | 86.00 Mil | -5.6% | Lower New | Guidance: 89.00 Mil for Q4 2025 | |
| Q1 2026 Production Enhancement Revenue | Reported | 42.00 Mil | 43.00 Mil | 44.00 Mil | -4.4% | Lower New | Guidance: 45.00 Mil for Q4 2025 | |
| Q1 2026 Revenue | Reported | 124.00 Mil | 127.00 Mil | 130.00 Mil | -5.2% | Lower New | Guidance: 134.00 Mil for Q4 2025 | |
| Q1 2026 Reservoir Description Operating Income | Reported | 6.80 Mil | 7.53 Mil | 8.25 Mil | -35.4% | Lower New | Guidance: 11.65 Mil for Q4 2025 | |
| Q1 2026 Production Enhancement Operating Income | Reported | 2.80 Mil | 3.30 Mil | 3.80 Mil | 0 | Same New | Guidance: 3.30 Mil for Q4 2025 | |
| Q1 2026 Operating Income | Reported | 9.70 Mil | 10.95 Mil | 12.20 Mil | -27.2% | Lower New | Guidance: 15.05 Mil for Q4 2025 | |
| Q1 2026 EPS | Reported | 0.11 | 0.13 | 0.15 | -35.0% | Lower New | Guidance: 0.2 for Q4 2025 | |
Q3 2025 Earnings Reported 10/22/2025
| Forward Guidance | Guidance Change | |||||||
|---|---|---|---|---|---|---|---|---|
| Metric | Source | Low | Mid | High | % Chg | % Delta | Change | Prior |
| Q4 2025 Reservoir Description Revenue | Reported | 88.00 Mil | 89.00 Mil | 90.00 Mil | 3.5% | Higher New | Actual: 86.00 Mil for Q3 2025 | |
| Q4 2025 Production Enhancement Revenue | Reported | 44.00 Mil | 45.00 Mil | 46.00 Mil | 0 | Same New | Actual: 45.00 Mil for Q3 2025 | |
| Q4 2025 Revenue | Reported | 132.00 Mil | 134.00 Mil | 136.00 Mil | 2.3% | Higher New | Actual: 131.00 Mil for Q3 2025 | |
| Q4 2025 Reservoir Description Operating Income | Reported | 11.00 Mil | 11.65 Mil | 12.30 Mil | 1.3% | Higher New | Actual: 11.50 Mil for Q3 2025 | |
| Q4 2025 Production Enhancement Operating Income | Reported | 2.90 Mil | 3.30 Mil | 3.70 Mil | 0 | Same New | Actual: 3.30 Mil for Q3 2025 | |
| Q4 2025 Operating Income | Reported | 14.00 Mil | 15.05 Mil | 16.10 Mil | 1.0% | Higher New | Actual: 14.90 Mil for Q3 2025 | |
| Q4 2025 EPS | Reported | 0.18 | 0.2 | 0.22 | 0 | Same New | Actual: 0.2 for Q3 2025 | |
Insider Activity
Updated 8/4/2026| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Bruno, Lawrence | Chairman and CEO | Direct | Buy | 8042026 | 10.78 | 5,000 | 53,900 | 2,829,082 | Form |
| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Bruno, Lawrence | Chairman and CEO | Direct | Buy | 8042026 | 10.78 | 5,000 | 53,900 | 2,829,082 | Form |
Industry Resources
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.
Core Cache Last Updated: 9/20/2026